• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UBI
Click for more information
13.3% 13.0¢

UNIVERSAL BIOSENSORS INC.

Market Cap $38.74M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing... Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
UBI
Ann: Q1 2024 Results Presentation - 31 March 2024 		09/05/24 2 737
09/05/24 Last post  BalkanBroker Comments Created with Sketch.  2  Views Created with Sketch.  737 
UBI
Ann: Appendix 3Y - Judith Smith 		09/05/24 0 99
09/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  99 
UBI
Ann: Appendix 3Y - Graham McLean 		09/05/24 0 97
TRENDING NEWS

What does it take to get a new drug to market in Australia?

Read More   right-arrow Created with Sketch.
NEWS
09 May 2024
09/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  97 
UBI
Ann: Top 20 and Distribution Schedule for Quoted Options 		09/05/24 4 733
09/05/24 Last post  BagsOBucks Comments Created with Sketch.  4  Views Created with Sketch.  733 
UBI
Ann: Application for quotation of securities - UBI 		08/05/24 0 104
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  104 
UBI
Ann: Application for quotation of securities - UBI 		08/05/24 0 95
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  95 
UBI
Ann: Completion of Entitlement Offer 		08/05/24 0 165
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  165 
UBI
Ann: Q1 2024 Results 		02/05/24 0 266
02/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 3Y - Judith Smith
09 May 10:54
 
Appendix 3Y - Graham McLean
09 May 10:53
 
Top 20 and Distribution Schedule for Quoted Options
08 May 10:07
 
Application for quotation of securities - UBI
08 May 09:49
 
Application for quotation of securities - UBI
08 May 09:46
 
Completion of Entitlement Offer
08 May 09:33
 
View More arrow Created with Sketch.

Featured News

ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
UNT UNITH's digital humans expand into Amazon; Facebook
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.

(20min delay)
Last
13.0¢ 		Change
-0.020(13.3%) 		Mkt cap ! $38.74M
Open High Low Value Volume
14.0¢ 14.0¢ 13.0¢ $91.21K 684.0K

Buyers (Bids)

No. Vol. Price($)
6 650580 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 190530 5
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
13.0¢ 		  Change
-0.020 ( 7.14 %)
Open High Low Volume
13.5¢ 14.0¢ 13.0¢ 250469
Last updated 15.31pm 09/05/2024 ?
UBI (ASX) Chart

Top Stories

Recce breathes better on positive lung infection drug pilot test results

Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.

Featured News

MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
RDN Raiden opens door to private Mallina in win-win Arrow Gold divestment
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.